A newly engineered antibody transport vehicle targeting the transferrin receptor enables enhanced delivery of anti-amyloid ...

Ever since Biogen and Eisai’s Aduhelm (aducanemab) was approved in 2021 as the first antibody to treat Alzheimer’s disease by ...